Janelle Barowski, MSN RN

Researchers evaluated the use of smoking cessation medications among individuals with and without HIV infection.

Researchers assessed whether daily zinc supplementation prevents severe or invasive infection among children with sickle cell anemia.

Researchers evaluated the risk for household COVID-19 transmission among adults and children with prior infection-induced immunity.

Researchers evaluated risk factors associated with persistent COVID-19 symptoms at 28 and 90 days following infection onset.

Researchers compared the risk for prolonged symptoms following COVID-19 infection among individuals infected during the pre-Delta, Delta, and Omicron periods.

Researchers evaluated patients hospitalized with complicated urinary tract infection to determine the optimal duration of antibiotic therapy.

Researchers evaluated the risk for various infections among patients with pemphigus who received rituximab vs those who received azathioprine or mycophenolate mofetil.

Researchers evaluated changes in menstruation following COVID-19 vaccination.

Researchers evaluated whether metformin use prior to hospitalization for community-acquired pneumonia decreases the risk of mortality in older patients with diabetes.

Researchers conducted a study to assess the long-term effects of COVID-19 infection in comparison with other common respiratory viral infections.

Researchers evaluated associations between various antihyperglycemic medications and the risk for COVID-19-related adverse outcomes in patients with diabetes.

Researchers evaluated the safety and efficacy of ensitrelvir for the treatment of mild to moderate COVID-19 infection during the Omicron wave.

Researchers compared the efficacy of azithromycin vs placebo to treat lower respiratory tract infections in patients with low procalcitonin levels.

Researchers compared the presence of symptoms 2 years after acute COVID-19 infection between hospitalized and nonhospitalized patients.

Researchers evaluated the short-term safety profile of a second booster dose of a COVID-19 mRNA vaccine.

Researchers evaluated the effectiveness of bivalent mRNA COVID-19 vaccination among adults who previously received at least 2 monovalent vaccine doses.